Research Topics
| Mark G TrombettaSummaryAffiliation: Allegheny General Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
The allegheny general modification of the Harvard Breast Cosmesis Scale for the retreated breastMark Trombetta
Department of Radiation Oncology, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA 15212, USA
Oncology (Williston Park) 23:954-6. 2009..We propose a modification of the scale for patients who undergo retreatment--the Allegheny General Modification of the Harvard/NSABP/RTOG scoring scale...
Mammary fat necrosis following radiotherapy in the conservative management of localized breast cancer: does it matter?Mark Trombetta
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Radiother Oncol 97:92-4. 2010..We wish to assess the clinical significance of fat necrosis resulting from post-lumpectomy breast irradiation...
Reduction in radiation-induced morbidity by use of an intercurrent boost in the management of early-stage breast cancerMark Trombetta
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Int J Radiat Oncol Biol Phys 77:1303-8. 2010..Herein, we compare patients treated with whole-breast irradiation followed by boost compared with a cohort with a planned intercurrent radiation boost...
Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breastMark Trombetta
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Am J Clin Oncol 32:314-8. 2009..To evaluate the cosmetic outcome of brachytherapy after lumpectomy in the management of carcinoma of the previously irradiated breast...
The use of the MammoSite balloon applicator in re-irradiation of the breastMark Trombetta
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Brachytherapy 7:316-9. 2008..To examine the feasibility of using the MammoSite brachytherapy applicator in the retreatment of the previously irradiated breast...
Paraganglioma: a potentially challenging tumorMark Trombetta
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA
Oncology (Williston Park) 22:341-3, 347, 350; discussion 350-2. 2008..The development of metastatic disease in patients with paraganglioma is an unusual and challenging event. This case report and review describes the specific features of this disease and the multiple therapeutic options...
Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lungMark G Trombetta
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Brachytherapy 7:50-4. 2008..A retrospective review to assess the efficacy and morbidity of surgical resection and (125)I interstitial lung brachytherapy placed in approximation to the aorta...
Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experienceMark Trombetta
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Brachytherapy 7:29-36. 2008..To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy...
Comparison of conservative management techniques in the re-treatment of ipsilateral breast tumor recurrenceMark Trombetta
Department of Radiation Oncology, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA
Brachytherapy 10:74-80. 2011..To compare brachytherapy and three-dimensional (3-D) conformal external beam radiotherapy for breast cancer presenting in the previously irradiated breast...
Comparison of single and multiple dwell position methods in MammoSite high dose rate (HDR) brachytherapy planningYongbok Kim
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212 4772, USA
J Appl Clin Med Phys 11:3235. 2010....
A comprehensive analysis of cardiac dose in balloon-based high-dose-rate brachytherapy for left-sided breast cancerVladimir Valakh
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA, USA
Int J Radiat Oncol Biol Phys 82:1698-705. 2012..To investigate radiation dose to the heart in 60 patients with left-sided breast cancer who were treated with balloon-based high-dose-rate brachytherapy using MammoSite or Contura applicators...
Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancerYongbok Kim
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA
Med Phys 34:4640-8. 2007..In addition, preliminary dermatologic adverse event assessment data suggested reduced skin toxicity for patients treated with the PBI technique...
Evaluation of the interfractional biological effective dose (BED) variation in MammoSite high dose rate brachytherapyYongbok Kim
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212 4772, USA
J Appl Clin Med Phys 11:3228. 2010....
Investigation of interfraction variations of MammoSite balloon applicator in high-dose-rate brachytherapy of partial breast irradiationYongbok Kim
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212 4772, USA
Int J Radiat Oncol Biol Phys 71:305-13. 2008..To measure the interfraction changes of the MammoSite applicator and evaluate their dosimetric effect on target coverage and sparing of organs at risk...
Objective method to report planner-independent skin/rib maximal dose in balloon-based high dose rate (HDR) brachytherapy for breast cancerYongbok Kim
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA
Med Phys 38:2053-7. 2011..An objective method was proposed and compared with a manual selection method to determine planner-independent skin and rib maximal dose in balloon-based high dose rate (HDR) brachytherapy planning...
Pacemaker/implantable cardioverter-defibrillator dose in balloon high-dose-rate brachytherapy for breast cancer treatmentYongbok Kim
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212 4772, USA
Brachytherapy 11:380-6. 2012..To retrospectively report pacemaker (PM)/implantable cardioverter-defibrillator (ICD) dose in balloon high-dose-rate (HDR) brachytherapy and provide distance-dose graph and table to approximately estimate the maximal device dose...
Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapyVladimir Valakh
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Am J Clin Oncol 34:245-8. 2011..To retrospectively compare radiation toxicity in patients treated with concurrent anastrozole and whole breast irradiation versus women treated sequentially with whole breast irradiation followed by hormonal suppression...
Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancerThomas J Birdas
Department of Cardiothoracic Surgery, Allegheny General Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Ann Thorac Surg 81:434-8; discussion 438-9. 2006..In this report, we present the outcomes of sublobar resection with brachytherapy compared with lobectomy in patients with stage Ib tumors...
Managing a small recurrence in the previously irradiated breast. Is there a second chance for breast conservation?Manjeet Chadha
Department of Radiation Oncology, Beth Israel Medical Center, USA
Oncology (Williston Park) 23:933-40. 2009..In this report, we review the controversial subject of a second chance at breast conservation for women with a prior history of breast irradiation...
Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancerMark Johnson
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA
Phys Med Biol 52:1237-45. 2007..Patient-related toxicity clinically measured by loss of pulmonary function and radiation-induced pneumonitis have not been linked to this procedure...
Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancerRicardo Santos
Division of General Thoracic Surgery, Department of Radiation Oncology, Allegheny General Hospital, 320 E. North Avenue, Pittsburgh, PA 15212, USA
Surgery 134:691-7; discussion 697. 2003..6%). This safe, pulmonary function-preserving and practical intraoperative brachytherapy method should be considered when SR is used as a "compromise" therapy in these patients...
Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapyAthanasios Colonias
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Int J Radiat Oncol Biol Phys 79:105-9. 2011..To update the Allegheny General Hospital experience of high-risk Stage I non-small-cell lung cancer patients treated with sublobar resection and intraoperative (125)I Vicryl mesh brachytherapy...
Local control and visual acuity following treatment of medium-sized ocular melanoma using a contact eye plaque: a single surgeon experienceBrian Karlovits
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Brachytherapy 10:228-31. 2011..To evaluate the outcomes of choroidal melanoma in (CM) patients treated with (125)I episcleral plaque brachytherapy and to compare our single surgeon results with the multi-institutional Collaborative Ocular Melanoma Study (COMS)...
